Canada· CA-DIN-02183056

VINBLASTINE SULFATE INJECTION

A vinblastine product containing vinblastine sulfate, registered in Canada by PFIZER CANADA ULC. The same ATC class is registered in 14 of our 19 countries.

ATC L01CA01

Checked against Health Canada Drug Product Database (Canada) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about vinblastine sulfateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Vinblastine is registered in 14 of 19 countries.

Countries holding a registration under ATC L01CA01 (vinblastine), each read from that country’s own register.

This record: Canada, from Health Canada Drug Product Database (Canada)
8 of them publish a price we can compare per daily dose

Search vinblastine products by name

Vinblastine · ATC L01CA01

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Netherlands
Norwayprice
Spainprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vinblastine costs, country by country.

Normalised to the WHO defined daily dose (11.61 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Vinblastine · price per daily dose (11.61 mg)

USD · FX 28 Sept 2026

CH Switzerland$56.28

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)

Active substance: VINBLASTINE SULFATE
Manufacturer: PFIZER CANADA ULC
Country: Canada (CA)
ATC code: L01CA01
ATC class: Vinblastine
Defined daily dose: 11.61 mg, P
Reimbursed: Not published by this register
Source register: Health Canada Drug Product Database (Canada)
Last checked: October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

416 interactions on record for vinblastine.

Graded by severity as the source publishes them — 61 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check vinblastine against other medicines How interaction checks work

Vinblastine · interactions on record

416 records

61 severe
303 moderate
24 minor
28 info

Most severe, free to view

LonafarnibA16AX20severe
ConivaptanC03XA02severe
KetoconazoleH02CA03severe
ErythromycinJ01FA01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vinblastine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vinblastine products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

Austria · Velbe
Belgium · Vinblastine Teva
Czechia · Vinblastin Teva
Germany · Vinblastin Stada, Vinblastinsulfat Teva
Denmark · Velbe
Estonia · Vinblastine Teva
Spain · Vinblastina Stada
Finland · Velbe
France · Velbe
United Kingdom (Northern Ireland) · Vinblastine Sulfate Hospira Uk
Ireland · Vinblastine Sulfate Pfizer Healthcare Ireland
Italy · Velbe
Lithuania · Vinblastine Teva
Luxembourg · Vinblastine Teva
Latvia · Vinblastine Teva
Malta · Vinblastine Sulfate Pfizer Hellas
Netherlands · Vinblastinesulfaat Pch
Norway · Velbe
Portugal · Solblastin
Romania · Vinblastină Teva
Sweden · Velbe

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/55fb5feb-bfb9-4a56-8bda-75ef4bee46a4
GET /v1/drugs/55fb5feb-bfb9-4a56-8bda-75ef4bee46a4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02183056",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "L01CA01",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "44270",
  "strengths": [
    "1 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "VINBLASTINE SULFATE"
  ],
  "product_categorization": null
}

API reference MCP server Plans

See everything about vinblastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console